Transcriptomic Analysis of Early-Stage Basal Cell Carcinomas in Murine Skin Following Topical Treatments With

Kristian Kåber Pedersen1, Merete Hædersdal1, Uffe Høgh Olesen1

  • 1Department of Dermatology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.

Experimental Dermatology
|October 9, 2024
PubMed

Insights

Ablative fractional laser (AFL) and vismodegib both reversed hedgehog pathway activation in basal cell carcinoma (BCC) models. AFL significantly increased immune cell infiltration, suggesting combination therapy potential.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Basal cell carcinoma (BCC) is a common skin cancer.
  • The hedgehog signaling pathway is crucial in BCC development.
  • Ablative fractional laser (AFL) has shown potential in treating BCCs.

Purpose of the Study:

  • To compare the transcriptomic effects of AFL and vismodegib on early-stage murine BCCs.
  • To investigate the impact of these treatments on gene expression and immune infiltration.

Main Methods:

  • RNA sequencing was used to analyze gene expression changes in murine skin with BCCs.
  • Ingenuity Pathway Analysis and gene set enrichment analysis were performed.
  • Cell type deconvolution was employed to assess immune cell infiltration.

Main Results:

  • BCC induction was associated with significant upregulation of 277 genes, primarily related to BCC and Sonic Hedgehog signaling.
  • Both AFL and vismodegib reversed these gene expression changes.
  • Vismodegib reversed more upregulated genes (180/277) than AFL (59/277).
  • Both treatments induced significant immune cell infiltration, with AFL causing greater recruitment of neutrophils, macrophages, and monocytes.

Conclusions:

  • AFL and vismodegib exhibit distinct molecular and immunological effects on BCC.
  • AFL enhances immune cell infiltration, suggesting potential for combination therapies.
  • Further research could explore combining AFL's immunomodulatory effects with other topical treatments for BCC.